Summit Therapeutics Inc.
Nasdaq: SMMTPharmaceutical Preparations · Entity-resolved by Clous
CIK0001599298
TickerSMMT
ExchangeNasdaq
SIC2834
State—
FY end12-31
Key financials
RevenueFY2024-12-31
$0
—
Net IncomeFY2025-12-31
-$1.08B
-387.8% YoY
Total AssetsFY2025-12-31
$751.18M
+72.5% YoY
EquityFY2025-12-31
$658.86M
+69.5% YoY
Shares OutstandingFY2025-12-31
775.37M
—
Operating Cash FlowFY2025-12-31
-$322.93M
-127.2% YoY
Market
Market
SMMTClose price
$13.77
Market cap
$10.69B
delayed EOD · as of 2026-06-18
Short interest & fails
Cost to borrow0.59%1.8M shares availableelevated
Short-sale volume
FINRA Reg SHO · daily69.0%
short of total volume · 2026-06-18
2026-06-1869.0%
2026-06-1767.7%
2026-06-1645.5%
2026-06-1546.1%
2026-06-1241.5%
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $705K | $0 | $0 | — | — | — |
| Net Income | -$78.78M | -$614.93M | -$221.32M | -$1.08B | -387.8% | — |
| Total Assets | $664.17M | $202.95M | $435.56M | $751.18M | +72.5% | — |
| Equity | $126.65M | $77.69M | $388.75M | $658.86M | +69.5% | — |
| Operating Cash Flow | -$41.58M | -$76.76M | -$142.11M | -$322.93M | -127.2% | — |
| Shares Outstanding | — | — | — | 775.37M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001599298